胰腺脂肪与硬度反映胰腺重塑及β细胞功能的不同特征
横断面研究纳入29例超声发现胰腺高回声但无糖尿病诊断者,以MRI质子密度脂肪分数(PDFF)定量胰腺脂肪,剪切波弹性成像评估组织硬度,并行口服葡萄糖耐量试验(OGTT)代谢表型。胰腺脂肪分数与BMI及β细胞葡萄糖敏感性正相关,胰腺硬度与体重及非葡萄糖依赖性胰岛素分泌增强因子比值(PFR1)负相关,脂肪与硬度间无相关。提示胰腺脂肪与硬度反映不同病理生理过程,与全身代谢状态及β细胞功能关系可能不同。
要点
- 胰腺脂肪分数与BMI及β细胞葡萄糖敏感性正相关。
- 胰腺硬度与体重及PFR1负相关,与胰腺脂肪分数无相关。
- 胰腺脂肪与硬度或为代谢功能障碍的异质性标志。
核心结论
- 胰腺内脂肪与胰腺硬度反映不同的病理生理过程,与全身代谢状态及β细胞功能的关系可能不同。
研究设计与样本
- 横断面研究,纳入29例超声检测胰腺高回声且既往无糖尿病诊断者(女16例/男13例,年龄54±10.4岁)。
- 以MRI质子密度脂肪分数(PDFF)定量胰腺脂肪,剪切波弹性成像评估胰腺硬度,口服葡萄糖耐量试验(OGTT)进行代谢表型分析。
主要发现
- 75.9%为正常糖耐量(NGT,n=22),24.1%为糖耐量受损(IGT,n=7)。
- MRI胰腺脂肪分数与BMI正相关(ρ=0.43,p=0.02),与β细胞葡萄糖敏感性正相关(ρ=0.40,p=0.03)。
- 胰腺硬度与体重负相关(ρ=-0.38,p=0.04),与胰腺脂肪分数无相关(ρ=-0.15,p=0.44)。
- 胰腺硬度与增强因子比值(PFR1)负相关(ρ=-0.44,p=0.02),PFR1反映非葡萄糖依赖性胰岛素分泌增强。
临床怎么用
- 对超声发现脂肪胰腺者,可考虑结合MRI PDFF与剪切波弹性成像分别评估胰腺脂肪与纤维化/硬度。
- 胰腺脂肪与硬度可能提供互补的代谢风险信息,不宜互相替代。
局限性
- 横断面设计无法推断因果关系。
- 样本量较小(n=29),结果需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Fatty pancreas is associated with obesity and metabolic alterations and may coexist with pancreatic structural remodeling. However, its contribution to β-cell dysfunction remains unclear. OBJECTIVE: We investigated the relationship between pancreatic fat, tissue remodeling, and β-cell function. DESIGN: We conducted a cross-sectional study in individuals with ultrasound-detected pancreatic hyperechogenicity without prior diagnosis of diabetes. Pancreatic fat was quantified by MRI-derived proton density fat fraction (PDFF), while tissue stiffness was assessed by shear-wave elastography. Metabolic phenotyping was based on oral glucose tolerance test (OGTT). PARTICIPANTS: We recruited 29 individuals with ultrasound-detected fatty pancreas (F/M 16/13, age 54 ± 10.4 years) and assessed glucose tolerance with OGTT: 75.9% exhibited normal glucose tolerance (NGT; n=22), while 24.1% had impaired glucose tolerance (IGT; n=7). RESULTS: MRI-derived pancreatic fat fraction was positively correlated with anthropometric measures (BMI ρ=0.43, p=0.02) and β-cell function (β-cell glucose sensitivity ρ=0.40, p=0.03). Pancreatic stiffness correlated negatively with body weight (ρ= -0.38, p=0.04), did not correlate with pancreatic fat fraction (ρ= -0.15, p= 0.44) and was correlated inversely with the potentiation factor ratio (PFR1; ρ= -0.44, p= 0.02), a measure of non-glucose-dependent amplification of insulin secretion. CONCLUSIONS: Intrapancreatic fat and pancreatic stiffness appear to reflect distinct pathophysiological processes, with potentially different relationships to systemic metabolic status and β-cell function. These findings support a more nuanced view of pancreatic structural alterations as heterogeneous markers of metabolic dysfunction.
引用
- De Lucia SS, Ciccarelli G, Gliozzo G, et al. Pancreatic Fat and Stiffness Reflect Distinct Features of Pancreatic Remodeling and β-Cell Function. J Clin Endocrinol Metab. 2026. PMID: 42809708. doi:10.1210/clinem/dgag399
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。